A metric for acute stroke care failed to identify preventable events in those patients requiring endovascular thrombectomy ...
While off-label use may be permissible, contraindicated use still has a strong regulatory boundary as reinforced by FDA guidance finalized in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback